Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ
Agonist in Diabetic Rat

Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat

Saved in:

Bibliographic Details
Main Authors:	Shohei Sakata, Yasuko Mera, Yukiharu Kuroki, Reiko Nashida, Makoto Kakutani, Takeshi Ohta
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/890639
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats
by: Shohei Sakata, et al.
Published: (2014-01-01)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
by: Jihan Youssef, et al.
Published: (2002-01-01)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
by: M. C. Thomas, et al.
Published: (2012-01-01)

The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase
by: Dapeng Zhang, et al.
Published: (2020-01-01)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
by: Silvia Martina Ferrari, et al.
Published: (2015-01-01)

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
by: Ahmad Aljada, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
by: Marion M. Chan, et al.
Published: (2012-01-01)

Leptin Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling in Growth Plate Chondrocytes
by: Lai Wang, et al.
Published: (2012-01-01)

A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase
by: Swati Valmiki, et al.
Published: (2025-01-01)

Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor
by: Seong-Hoon Yun, et al.
Published: (2018-01-01)

Effects of Dual Peroxisome Proliferator-Activated Receptors α and γ Activation in Two Rat Models of Neuropathic Pain
by: Mohammad Alsalem, et al.
Published: (2019-01-01)

Peroxisome Proliferator-Activated Receptor-𝛾 Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer
by: Masahide Matsuyama, et al.
Published: (2008-01-01)

Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice
by: Makoto Ito, et al.
Published: (2014-01-01)

To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations
by: Holli-Joi Sullivan, et al.
Published: (2020-01-01)

Peroxisome Proliferator-Activated Receptor γ Regulates the Expression of Lipid Phosphate Phosphohydrolase 1 in Human Vascular Endothelial Cells
by: Yazi Huang, et al.
Published: (2014-01-01)

Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01)

Molecular docking of ferulic acid, bakuchiol and niazirin on peroxisome proliferator-activated receptor gamma (PPAR-γ) as anti-diabetic agents
by: Anjar Hermadi Saputro, et al.
Published: (2024-08-01)

Peroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages
by: G. Chinetti-Gbaguidi, et al.
Published: (2016-01-01)

WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis
by: Enrico Briguglio, et al.
Published: (2010-01-01)

Mechanisms Involved in the Enhanced Susceptibility of Senescent Rats to the Hepatocarcinogenic Effect of Peroxisome Proliferators: Role of Peroxisome Proliferator-Activated Receptor alpha (PPAR), Cell Proliferation and Oxidative Stress
by: Jihan A. Youssef, et al.
Published: (2001-01-01)

Peroxisome proliferator–activated receptor delta and liver diseases
by: Tomoo Yamazaki, et al.
Published: (2025-02-01)

GABA promotes peroxisome proliferation in Triticum monococcum leaves
by: Yunus Şahin, et al.
Published: (2024-10-01)

Peroxisome Proliferator-Activated Receptor Alpha Target Genes
by: Maryam Rakhshandehroo, et al.
Published: (2010-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer
by: Joo-In Park, et al.
Published: (2012-01-01)

Peroxisome Proliferator-Activated Receptors and Acute Lung Injury
by: Rosanna Di Paola, et al.
Published: (2007-01-01)

Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility
by: Maurizio Vitti, et al.
Published: (2016-01-01)

Peroxisome Proliferator-Activated Receptor γ Regulates Lipid Metabolism in Sheep Trophoblast Cells through mTOR Pathway-Mediated Autophagy
by: Kexing Hao, et al.
Published: (2023-01-01)

Peroxisome Proliferator-Activated Receptor-γ Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p
by: Lei Xu, et al.
Published: (2019-01-01)

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration
by: Chi-Chao Chan, et al.
Published: (2008-01-01)

A Role for Peroxisome Proliferator-Activated Receptors in the Immunopathology of Schistosomiasis?
by: Barrie J. Anthony, et al.
Published: (2012-01-01)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
by: Runzhi Huang, et al.
Published: (2020-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
by: Rachel E. Nisbet, et al.
Published: (2007-01-01)

Placental Implications of Peroxisome Proliferator-Activated Receptors in Gestation and Parturition
by: Valerie Borel, et al.
Published: (2008-01-01)

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
by: Francisco A. Monsalve, et al.
Published: (2013-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Altered Peroxisome-Proliferator Activated Receptors Expression in Human Endometrial Cancer
by: Paweł Knapp, et al.
Published: (2012-01-01)